1. Home
  2. LSPD vs NNNN Comparison

LSPD vs NNNN Comparison

Compare LSPD & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightspeed Commerce Inc. Subordinate Voting Shares

LSPD

Lightspeed Commerce Inc. Subordinate Voting Shares

HOLD

Current Price

$9.33

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$28.60

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LSPD
NNNN
Founded
2005
2021
Country
Canada
Germany
Employees
N/A
27
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
LSPD
NNNN
Price
$9.33
$28.60
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$13.33
N/A
AVG Volume (30 Days)
807.6K
11.2K
Earning Date
05-21-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.43
N/A
Revenue Next Year
$10.94
N/A
P/E Ratio
N/A
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$8.37
$6.26
52 Week High
$14.34
$55.65

Technical Indicators

Market Signals
Indicator
LSPD
NNNN
Relative Strength Index (RSI) 51.73 64.30
Support Level $8.45 $26.48
Resistance Level $9.71 $30.21
Average True Range (ATR) 0.32 1.60
MACD -0.02 0.05
Stochastic Oscillator 36.94 91.77

Price Performance

Historical Comparison
LSPD
NNNN

About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares

Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, United Kingdom, Australia, and other countries. It derives a majority of its revenue from the United States.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: